฿6.22
+฿0.12(+1.96%)
data.updated
v2.stock.overview v2.daily.trading v2.range.52w
key.stats
yesterday.close฿6.16
market.size฿264.97M
volume.trade585.11K
pe.ratio-3.33
div.yield0.00%
diluted.eps1.91
net.income-฿69.11M
revenue฿35.25M
earnings.date2026-08-06
eps.estimate0.61
rev.estimate฿13.35M
shares.out43.01M
beta1.0557685
about.stock
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
sectorHealthcare
industryMedical - Devices
ceoTimothy T. Goodnow
headquartersGermantown,MD,US
websitehttps://www.senseonics.com
employees130.00
avg.revenue฿271.20K
income.per.emp-฿531.63K
stock.faq
stock.price
x
current.stats
52w.range.q
x
pe.ratio.q
x
market.cap.q
x
eps.recent.q
x
buy.sell.q
x
price.factors
x
buy.how
x
risk.warn
risk.notice
disclaimer2
risk.disclosure
